Navigation Links
Children's Hospital neurosurgeon receives grant
Date:1/8/2008

Childrens Hospital of Pittsburgh of UPMCs Chief of the Division of Pediatric Neurosurgery Ian F. Pollack, MD, has received a grant from the Childrens Brain Tumor Foundation for his pioneering work in the field of neuro-oncology.

Awarded for his project, Molecular Makers of Outcome in Childhood Oligodendrogliomas, Dr. Pollacks research focuses on a category of brain tumors that he says has previously not been well studied in children.

Were identifying the molecular features of the tumor, which will allow doctors to better tailor a specific treatment for the patient, Dr. Pollack said. For example, we are looking forward to the day when physicians can predict which patients will respond to new therapies and which will benefit from more conventional treatments.

Dr. Pollack said Childrens Hospital has continued to serve as a leader in this type of research because of the continued support of foundations like the Childrens Brain Tumor Foundation. This grant totaled $150,000.

This grant, and others we have received previously, will enable us to explore new areas of brain tumor research at Childrens and broaden our scope on eventual treatments, Dr. Pollack said.

Dr. Pollacks primary research interests focus on identifying and evaluating innovative strategies for classifying and treating malignant brain tumors, improving the treatment of children with brain tumors and optimizing the management of childhood craniofacial disorders. He has been listed in Best Doctors in America and Whos Who in Science and Engineering and has been awarded several research grants from the National Institutes of Health.

Dr. Pollack represents the epitome of the translational researcher and is one of the very few true neurosurgical physician-scientists in the nation, said Amin Kassam, MD, associate professor and chair, Department of Neurological Surgery at the University of Pittsburgh School of Medicine and UPMC. Accordingly, this allows us to remain at the forefront of neuro-oncology in the nation.

In July, Dr. Pollack was awarded $200,000 in funding from the Brain Tumor Society, for his study titled, Predictors of Outcome in Pediatric Low-Grade Astrocytomas. According to Dr. Pollack, this project focuses on the most common type of pediatric brain tumors, but the goal is similar: to better characterize the molecular changes that are associated with tumor development and recurrence, so that treatments can be better targeted to those tumors at high risk for regrowth.


'/>"/>

Contact: Marc Lukasiak
marc.lukasiak@chp.edu
412-692-7919
Children's Hospital of Pittsburgh
Source:Eurekalert

Related biology news :

1. Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery
2. Childrens Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
3. Nationwide Childrens Hospital involved in expanded access program for treatment of PKU
4. 3 out of 4 hospital patients suffer from malnutrition regardless of their pathology
5. Seattle Childrens Hospital leads $23.7 million NIH grant to study gene repair
6. Study finds environmental tests help predict hospital-acquired Legionnaires disease risk
7. Computational mathematical sciences receives NSF grant for undergraduate research
8. K-State specialist in tick-borne pathogens receives $1.8 million grant
9. Liang receives NIH grant for biofilm research
10. CONRAD receives $28.5M Gates Foundation grant for HIV prevention research
11. Univ. of Arizona receives $2.5 million to study Amazon forests and climate change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... ... Amgen, will join the faculty of the University of North Carolina Kenan-Flagler ... of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s ...
(Date:6/24/2016)... -- Regular discussions on a range of subjects including policies, debt ... said Poloz. Speaking at a lecture to the ... pointed to the country,s inflation target, which is set by ... "In certain areas there needs to ... goals, why not sit down and address strategy together?" ...
(Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology: